CEP55 and breast carcinoma: Considering that premature exit by impairing death signaling cascades have been implicated in resistance to microtubule poisons (Manchado et al, 2012), we questioned whether high expression of CEP55 could also contribute to chemotherapeutic resistance, particularly to docetaxel, which is widely used in breast cancer management.